Evidence map›Paper›PMID 30319759›Full record

ArticleCatalysis science & technology2018

Harnessing asymmetric N-heterocyclic carbene ligands to optimise SABRE hyperpolarisation.

Chin Min Wong, Marianna Fekete, Rhianna Nelson-Forde, Mark R D Gatus, Peter J Rayner, Adrian C Whitwood, Simon B Duckett, Barbara A Messerle

Abstract read
In one paragraph

Article in Catalysis science & technology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Reversible Hyperpolarization of Ketoisocaproate Using Sulfoxide-containing Polarization Transfer Catalysts.Chemphyschem : a European journal of chemical physics and physical chemistry · 2021
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Chin Min WongSchool of Chemistry , University of New South Wales , Sydney 2052 , Australia.
Marianna FeketeCentre for Hyperpolarisation in Magnetic Resonance , York Science Park , University of York , Heslington , York YO10 5NY , UK . Email: simon.duckett@york.ac.uk.ORCID 0000-0003-4869-0912
Rhianna Nelson-FordeCentre for Hyperpolarisation in Magnetic Resonance , York Science Park , University of York , Heslington , York YO10 5NY , UK . Email: simon.duckett@york.ac.uk.
Mark R D GatusDepartment of Molecular Sciences , Macquarie University , North Ryde 2109 , Australia . Email: barbara.messerle@mq.edu.au.ORCID 0000-0002-1027-9311
Peter J RaynerCentre for Hyperpolarisation in Magnetic Resonance , York Science Park , University of York , Heslington , York YO10 5NY , UK . Email: simon.duckett@york.ac.uk.ORCID 0000-0002-6577-4117
Adrian C WhitwoodCentre for Hyperpolarisation in Magnetic Resonance , York Science Park , University of York , Heslington , York YO10 5NY , UK . Email: simon.duckett@york.ac.uk.ORCID 0000-0002-5132-5468
Simon B DuckettCentre for Hyperpolarisation in Magnetic Resonance , York Science Park , University of York , Heslington , York YO10 5NY , UK . Email: simon.duckett@york.ac.uk.ORCID 0000-0002-9788-6615
Barbara A MesserleDepartment of Molecular Sciences , Macquarie University , North Ryde 2109 , Australia . Email: barbara.messerle@mq.edu.au.ORCID 0000-0002-1928-5961

Funding

Medical Research Council MR/M008991/1Wellcome Trust 092506Wellcome Trust 098335
6 · The paper itself

Abstract

The catalytic signal amplification by reversible exchange process has become widely used for the hyperpolarisation of small molecules to improve their magnetic resonance detectability. It harnesses the latent polarisation of

Identifiers

PMID30319759
PMCPMC6171487

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.